Weight Loss Research, Health Insights & Smarter Choices
ravitiku
GLP-1 Side Effects and Serious Risks: What to Know in 2026 Introduction GLP-1-based medicines have become some of the most important tools in modern obesity treatment. Wegovy, Zepbound and related medicines can help eligible patients achieve significant weight loss. But their growing popularity has also made one issue increasingly important-mainly ‘GLP-1 side effects’: What should … Read more
People who come off slimming jabs have weight regain four times faster than dieters Introduction GLP-1 weight-loss drugs have changed obesity treatment. Medicines such as Wegovy and Zepbound can help people lose substantial amounts of weight by reducing appetite and increasing feelings of fullness. But an important question remains: why does weight regain often happen … Read more
Quitting GLP-1 drugs triggers rapid regain, but 25% of weight loss may last Medicines such as Ozempic and Wegovy have changed the treatment of type 2 diabetes and obesity. Many people achieve significant weight loss with GLP-1 medicines. But the results are not identical for everyone. Some people lose more weight than others. Some experience … Read more
How Semaglutide Works as oral Weight Loss drugs and in Type 2 Diabetes For years, injectable medicines dominated the conversation around modern weight-loss treatment. That picture is changing rapidly in 2026. New oral weight loss drugs are now available, while researchers are also testing completely different approaches that target metabolism and skeletal muscle. One of … Read more
GLP-1 drug semaglutide may help heavy drinkers cut alcohol intake, reduce cravings, and offer a promising new addiction treatment.
Quitting GLP-1 drugs or a diet can cause weight regain—two strategies could help prevent Millions of Americans are now using GLP-Drugs such as Wegovy and Zepbound to lose weight and improve their health. These medicines can produce significant weight loss. But an important question remains: What happens when treatment stops? Research shows that weight regain … Read more
Weight Loss Drug Market Could Reach $150 Billion Globally | Morgan Stanley The race to develop obesity drugs is entering a new phase. For several years, the biggest question was simple: How much weight can a drug help people lose? Now the focus is changing. Doctors and researchers are increasingly asking whether patients can maintain … Read more
How weight loss drugs may trigger severe muscle loss | – The Times of India GLP-1 and related weight-loss medicines have changed the treatment of obesity. Medicines such as semaglutide and tirzepatide can help many people lose substantial amounts of weight and improve important health measures. But weight loss is not made up of body … Read more
Research for ‘New weight-loss drug without muscle loss’ is increasingly focused on reducing body fat while preserving muscle. Losing weight is not always the same as losing body fat. Some people taking modern weight-loss medicines can lose lean mass along with fat. That has increased interest in treatments that could target body fat while doing … Read more